ArticleEuropean heart journal open2026
Relationship between early use of tocilizumab during chimeric antigen receptor T-cell therapy for multiple myeloma and cardiovascular risk and progression-free survival.
Sophia Golec et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.